Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11964014 Vaccine adjuvants based on TLR receptor ligands

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
August 8, 2023
0
Date of Patent
April 23, 2024
0
Patent Application Number
18446041
0
Patent Citations
‌
US Patent 8067413 9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7 ) modulators
0
‌
US Patent 8729088 Toll-like receptor modulators and treatment of diseases
0
‌
US Patent 8624029 Lipidated imidazoquinoline derivatives
0
‌
US Patent 9044481 Lipidated oxoadenine derivatives
0
‌
US Patent 7063967 Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
0
‌
US Patent 7960522 Certain aminoalkyl glucosaminide phosphate compounds and their use
0
Patent Inventor Names
David Burkhart
0
Helene Bazin-Lee
0
Jay Evans
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11964014
0
Patent Primary Examiner
‌
Adam C Milligan
0
CPC Code
‌
A61K 2039/55511
0
‌
C07F 9/65616
0
‌
A61K 2039/55505
0
‌
A61K 39/39
0

Find more entities like US Patent 11964014 Vaccine adjuvants based on TLR receptor ligands

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo